Document is current
Any future updates will be listed below
-
Authors
Duminy-Luppi, D.
Alcaide-Aldeano, A.
Planas-Cerezales, L.
Bermudo, G.
Vicens-Zygmunt, V.
Luburich, P.
Del Río-Carrero, B.
Llatjós, R.
Pijuan, L.
Escobar, I.
Rivas, F.
Montes-Worboys, A.
Gutiérrez-Rodríguez, Y.
Rodríguez-Plaza, D.
Padró-Miquel, A.
Esteve-Garcia, A.
Fernández-Varas, B.
Flores, C.
Fuentes, M.
Dorca, J.
Santos, S.
Perona, R.
Günther, A.
Shull, J.
Molina-Molina, M.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III and the European Joint Programme on Rare Diseases (AC19/00006)
Ministerio de Ciencia e Innovación (RTC-2017-6471-1; AEI/FEDER, UE)
Instituto Tecnológico y de Energías Renovables (OA17/008 and OA23/043)
Cabildo Insular de Tenerife (CGIEU0000219140)
Boehringer Ingelheim through Fundación Catalana de Pneumologia
CERCA Program
- License Information
-
More Information
Article History
Received: 9 June 2024
Accepted: 4 December 2024
First Online: 18 December 2024
Declarations
:
: The Ethics Committee of HUB approved the study (PR307/16), and all patients provided written informed consent before inclusion, including written informed consent for genetic testing if needed.
: Not applicable.
: Not applicable.
: MMM has received grants for research purposes and fees for scientific advice outside this work from Boehringer Ing, Ferrer, Roche, Veracyte and Chiesi. The other authors of this work have no conflicts of interest to disclose.
